Keywords: gilead, preveon, sees, success, hiv, hep, sciences

Gilead's Preveon Sees Success In HIV And Hep B

Article | 08 April 1998

Gilead Sciences has revealed preliminary data from a Phase II/III trialof its reverse transcriptase inhibitor Preveon (adefovir cipivoxil), which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Gilead Sciences

Giliad Sciences

Merck

Merck KGaA

Schering Plough

Go to company listing

Related Drugs

Epivir

Lamivudine

Retrovir

Zidovudine

Stavudine

Go to drug listing